Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04741438
Title Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype (RAR-Immune)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Centre Leon Berard
Indications

inflammatory myofibroblastic tumor

angiosarcoma

malignant epithelioid hemangioendothelioma

sarcoma

fibrosarcoma

epithelioid sarcoma

alveolar soft part sarcoma

perivascular epithelioid cell tumor

malignant peripheral nerve sheath tumor

clear cell sarcoma

desmoplastic small round cell tumor

solitary fibrous tumor/hemangiopericytoma

extraskeletal myxoid chondrosarcoma

chordoma

Therapies

Ipilimumab + Nivolumab

Pazopanib

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.